Maintenance over Time of the Effect Produced by Esmolol on the Structure and Function of Coronary Arteries in Hypertensive Heart Diseases
Authors:
- Raquel Martín-OropesaRMRaquel Martín-Oropesa
- Pilar Rodríguez-RodríguezPRPilar Rodríguez-Rodríguez
- Laia Pazó-SayósLPLaia Pazó-Sayós
- Ana Arnalich-MontielAAAna Arnalich-Montiel
- Silvia Magdalena ArribasSilvia Magdalena Arribas
- Maria Carmen GonzálezMGMaria Carmen González
- Begoña Quintana-VillamandosBQBegoña Quintana-Villamandos
Open Access
- 17 October 2022
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 11 (10) , 2042
Abstract
We previously observed that esmolol treatment for 48 h reduced vascular lesions in spontaneously hypertensive rats (SHRs). Therefore, we investigated whether this beneficial effect is persistent after withdrawal. Fourteen-month-old SHRs (SHR-Es) were treated with esmolol (300 μg/kg/min) or a vehicle for 48 h. Two separate groups were also given identical treatment, but they were then monitored for a further 1 week and 1 month after drug withdrawal. We analyzed the geometry and composition of the coronary artery, vascular reactivity and plasma redox status. Esmolol significantly decreased wall thickness (medial layer thickness and cell count), external diameter and cross-sectional area of the artery, and this effect persisted 1 month after drug withdrawal. Esmolol significantly improved endothelium-dependent relaxation by ACh (10−9–10−4 mol/L); this effect persisted 1 week (10−9–10−4 mol/L) and 1 month (10−6–10−4 mol/L) after withdrawal. Esmolol reduced the contraction induced by 5-HT (3 × 10−8–3 × 10−5 mol/L), and this effect persisted 1 week after withdrawal (10−6–3 × 10−5 mol/L). Esmolol increased nitrates and reduced glutathione, and it decreased malondialdehyde and carbonyls; this enhancement was maintained 1 month after withdrawal. This study shows that the effect of esmolol on coronary remodeling is persistent after treatment withdrawal in SHRs, and the improvement in plasma oxidative status can be implicated in this effect.Keywords
Funding Information
- Instituto de Salud Carlos III (PI16/02069)
This publication has 38 references indexed in Scilit:
- Characteristic interactivity of landiolol, an ultra-short-acting highly selective β1-blocker, with biomimetic membranes: Comparisons with β1-selective esmolol and non-selective propranolol and alprenololFrontiers in Pharmacology, 2013
- Clinical Pharmacokinetics and Therapeutic Efficacy of EsmololClinical Pharmacokinetics, 2012
- EsmololDrugs, 2012
- Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertensionJournal Of Hypertension, 2011
- Remodelling of the heart and vessels in experimental hypertension: advances in protectionJournal Of Hypertension, 2010
- Quantification of protein modification by oxidantsFree Radical Biology and Medicine, 2009
- Caspase-Dependent Cell Death Mediates the Early Phase of Aortic Hypertrophy Regression in Losartan-Treated Spontaneously Hypertensive RatsCirculation Research, 2003
- Vascular Remodeling in HypertensionHypertension, 2001
- Vascular Remodeling and Endothelial Function in Hypertensive Patients: Effects of Antihypertensive TherapyScandinavian Cardiovascular Journal, 1998
- Smooth Muscle Apoptosis During Vascular Regression in Spontaneously Hypertensive RatsHypertension, 1997